Industry NewsXEOMIN® FDA Approved For Forehead, Frown Lines & Crow’s FeetXEOMIN® approved by FDA as the first and only neurotoxin for simultaneous treatment of upper facial lines.July 23, 2024
Industry NewsExpansion of the U.S. Medical Spa IndustryKey Summary & Takeaways From The 2022 Medical Spa State of the Industry Report.January 1, 2024
Industry NewsHow Investment Bankers View the Medical Spa IndustryOverview of how investors think about the medical spa industry.December 30, 2023